SAM
WST icon

Smartleaf Asset Management’s West Pharmaceutical WST Stock Holding History

Smartleaf Asset Management’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$292K Sell
1,190
-17
-1% -$4.23K 0.01% 665
2025
Q4 		$334K Buy
1,207
+53
+5% +$14.5K 0.01% 618
2025
Q3 		$300K Buy
1,154
+354
+44% +$86K 0.02% 604
2025
Q2 		$175K Sell
800
-36
-4% -$7.7K 0.02% 618
2025
Q1 		$186K Sell
836
-78
-9% -$21.5K 0.02% 598
2024
Q4 		$301K Buy
914
+248
+37% +$78K 0.03% 437
2024
Q3 		$207K Buy
666
+114
+21% +$34.9K 0.03% 487
2024
Q2 		$181K Buy
552
+56
+11% +$19.8K 0.03% 409
2024
Q1 		$195K Buy
496
+32
+7% +$11.8K 0.04% 363
2023
Q4 		$165K Buy
+464
New +$164K 0.04% 348

Other funds holding WST

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $61.3B AUM 26.25% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
GIM
Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return